SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-229599
Filing Date
2021-07-30
Accepted
2021-07-29 19:22:04
Documents
15
Period of Report
2021-07-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d198092d8k.htm   iXBRL 8-K 33447
2 EX-99.1 d198092dex991.htm EX-99.1 8053
7 GRAPHIC g198092g0727232806226.jpg GRAPHIC 3675
  Complete submission text file 0001193125-21-229599.txt   210022

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20210729.xsd EX-101.SCH 3539
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20210729_def.xml EX-101.DEF 13422
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20210729_lab.xml EX-101.LAB 22453
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20210729_pre.xml EX-101.PRE 14225
8 EXTRACTED XBRL INSTANCE DOCUMENT d198092d8k_htm.xml XML 6408
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 211129298
SIC: 2836 Biological Products, (No Diagnostic Substances)